Statutory Committee inquiries
The Statutory Committee will meet at the Royal Pharmaceutical Society of Great
Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 18 July Tuesday
19 July, Wednesday 20 July and Thursday 21 July 2005 to hear the following inquiries.
Monday 18 July
1. The committee will consider an application for restoration by Dilip
Patel (registration number 73918) whose name has been removed from the register.
2. The committee will deliver its decision, together with reasons, in an inquiry
into a complaint by the Council of the Society against Alan Roch (registration
number 67574) and Honeysgreen Pharmacy Ltd (identification number 1088653)
which alleged that (a) failure to have in place professional indemnity insurance
cover in respect of the professional activities carried on in the pharmacy,
(b) failure to ensure that adequate procedures were in place or instructions
given to non-pharmacist staff in relation to the non-arrival of a pharmacist
for duty and (c) failure between October 2001 and August 2003 to take adequate
steps regarding the supervision of non-general sale list medicines, after advice
was given on the subject in October 2001 may have amounted to misconduct. In
addition, a conviction against Mr Roch for the supply of bendrofluazide, fluconazole
and Cilest tablets when such supply was not made by a pharmacist or by a person
acting under the supervision of a pharmacist.
Tuesday 19 July
3. An inquiry into the case of John Gilpin (registration number 1055670) who
has been convicted of 15 counts of fraud.
4. An inquiry into the case of Malcolm Dexter (registration number 66371) who
has been convicted of three counts of possession of indecent
pseudophotographs of children.
Wednesday 20 July
5. An inquiry into a complaint by the Council of the Society against James
Newman (registration number 1072633) which alleges that (a) an unreasonable
refusal to dispense prescriptions [or certain items on prescriptions] for
patients, (b) inappropriate remarks to a patient; inappropriate behaviour
towards colleagues, a patient and a daughter of a patient, (c) unprofessional
conduct in the presence of members of the public, (d) failure to act in the
best interests of patients, (e) frequent late arrival for duty with the consequent
disruption of pharmaceutical services to members of the public, (f) concealment
from employers of excessive purchases of codeine linctus for his own use
and purchases of co-codamol also for his own use and (g) failure to disclose
to a new employer the fact that he had received a written warning from a
previous employer may amount to misconduct.
Thursday 21 July
6. The committee will resume consideration of an inquiry into a complaint by
the Council of the Society against Peter Herman (registration number 63167)
which alleges that the commission of offences of distributing by way of wholesale
dealing products otherwise than in accordance with a wholesale dealer’s
license may amount to misconduct.
7. An inquiry into the case of Shariff Obadi (registration number 89030) who
has been convicted of three counts of obtaining pecuniary advantage by deception,
one count of theft, three counts of possessing a class A Controlled Drug, namely,
methadone, and assault by beating.
8. The committee will resume consideration of an inquiry into the case of David
Beldon (registration number 62802) who has been convicted of driving with an
alcohol level which exceeded the prescribed limit.
David Gomez
Secretary to the Statutory Committee |
The
Pharmaceutical Journal